Advertisement

Topics

J&J's Caruso bullish on Remicade defence plans

06:35 EDT 19 Oct 2016 | PMLIVE

Believes top-selling arthritis treatment will weather introduction of biosimilars in US market

Original Article: J&J's Caruso bullish on Remicade defence plans

NEXT ARTICLE

More From BioPortfolio on "J&J's Caruso bullish on Remicade defence plans"

Quick Search
Advertisement
 

Relevant Topics

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...